Cascade testing is tried and tested and cost effective

BMJ

Volumn 335, Issue 7622, 2007, Pages 683-

  Hadfield, Gaye S ^a   Humphries, Steve E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; COST BENEFIT ANALYSIS; ECONOMICS; GENETIC SCREENING; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; NOTE; ANXIETY; COST EFFECTIVENESS ANALYSIS; FAMILIAL HYPERCHOLESTEROLEMIA; FEASIBILITY STUDY; GENERAL PRACTICE; HEALTH CARE PLANNING; HEART INFARCTION; IMMUNIZATION; LABORATORY TEST; LETTER; MEDICAL RECORD; NATIONAL HEALTH SERVICE; NEWBORN SCREENING; PILOT STUDY; PRIORITY JOURNAL;

CHILD; COST-BENEFIT ANALYSIS; GENETIC SCREENING; HUMANS; HYPERLIPOPROTEINEMIA TYPE II;

CHOLESTEROL; DNA;

EID: 35248871679     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.39353.483160.BE     Document Type: Letter

References (5)

1. Wald DS, Bestwick JP, Wald NJ. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis. BMJ 2007; 335: 599-603. (22 September.)
2. Marks D, Wonderling D, Thorogood M, Lambert H, Humphries SE, Neil AW. Cost-effectiveness analysis of different approaches of screening for familial hypercholesterolaemia. BMJ 2002; 324: 1303-6.
3. Marks D, Thorogood M, Farrer M, Humphries SE. Census of clinics providing specialist lipid services in the United Kingdom. J Public Health Med 2004; 26: 353-4.
4. Bhatnagar D, Morgan J, Siddiq S, Mackness MI, Miller JP, Durrington PN. Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia. BMJ 2000; 321: 1497-500.
5. Gray J, Jaiyeola A, Whiting M, Model M, Wierzbicki A. Identifying patients with familial hypercholestrolaemia in primary care: an informatics-based approach in one primary care centre. Heart 2007 Jun 17; [Epub ahead of print]